Development of a physiological microsystem, from a blood-brain barrier-on-chip to a vascularized glioblastoma-on-chip - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Development of a physiological microsystem, from a blood-brain barrier-on-chip to a vascularized glioblastoma-on-chip

Résumé

The blood-brain barrier (BBB) limits the transport of drugs and nanocarriers, and hampers the development of innovative therapeutic solutions against neurological disorders. The fight against most common and aggressive brain tumor, the glioblastoma multiforme (GBM), faces too many therapeutic failures, with a survival after diagnosis of 12 to 18 months only.  The preclinical screening of innovative drug candidates relies on conventional 2D in vitro models which may be too simplistic, and animal experimentation with ethical issues and interspecies differences. Poor translational results in clinical assays are unfortunately the norm. Tissue engineering and physiological microsystems, as organ-on-chips, promise alternative models that mimic a complex microenvironment in healthy or pathological contexts: the 3D organization of different human cell types, the extracellular matrix, and the chemical gradients and mechanical constraints of the blood flow.
Fichier principal
Vignette du fichier
5c5b2999-a440-465d-be41-89e91cbec0d9-author.pdf (168.13 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04680288 , version 1 (28-08-2024)

Identifiants

  • HAL Id : hal-04680288 , version 1

Citer

Agathe Figarol, Roumaïssa Mosbah, Michiya Matsusaki, Asuka Yamada, Tomomi Furihata, et al.. Development of a physiological microsystem, from a blood-brain barrier-on-chip to a vascularized glioblastoma-on-chip. Cancéropole Grand Sud-Ouest, Nov 2023, ARCACHON, France. ⟨hal-04680288⟩
0 Consultations
0 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More